Bette Caan to Double-Blind Method
This is a "connection" page, showing publications Bette Caan has written about Double-Blind Method.
Connection Strength
0.655
-
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause. 2015 Jun; 22(6):607-15.
Score: 0.125
-
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008 Nov 19; 100(22):1581-91.
Score: 0.079
-
Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007 May 14; 167(9):893-902.
Score: 0.072
-
Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial. Am J Epidemiol. 2012 Jul 01; 176(1):1-13.
Score: 0.051
-
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol. 2015 Aug; 126(2):413-22.
Score: 0.032
-
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes. Sleep. 2015 Jan 01; 38(1):97-108.
Score: 0.030
-
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause. 2014 Apr; 21(4):347-54.
Score: 0.029
-
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause. 2014 Apr; 21(4):339-46.
Score: 0.029
-
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause. 2014 Jan; 21(1):45-58.
Score: 0.028
-
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements. Am J Obstet Gynecol. 2014 Mar; 210(3):244.e1-11.
Score: 0.028
-
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer. 2011; 63(6):827-41.
Score: 0.024
-
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011 Jan 19; 305(3):267-74.
Score: 0.023
-
Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause. 2010 Jul; 17(4):683-91.
Score: 0.022
-
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas. 2006 Sep 20; 55(2):103-15.
Score: 0.017
-
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006 May 23; 113(20):2425-34.
Score: 0.017
-
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16; 354(7):669-83.
Score: 0.016
-
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006 Feb 16; 354(7):684-96.
Score: 0.016
-
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701-12.
Score: 0.014
-
Behavioral responses to artificial food colors. Science. 1980 Mar 28; 207(4438):1487-9.
Score: 0.003